Evidence map›Paper›PMID 41714435›Full record

ArticleAnnals of hematology2026

A novel frameshift deletion in SLC25A38 and its role in mitochondrial dysfunction: A case study of sideroblastic anemia in a child from Iran.

Elaheh Hasani, Maryam Naghinejad, Moein Kohkalani, Sima Mansoori Derakhshan, Mahmoud Shekari Khaniani

Abstract readCase Reports
In one paragraph

Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elaheh HasaniDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Maryam NaghinejadDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Moein KohkalaniDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Sima Mansoori DerakhshanDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. mansooris@tbzmed.ac.ir.
Mahmoud Shekari KhanianiDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Shekarima@tbzmed.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sideroblastic anemia (SA) is a rare hematological condition characterized by the accumulation of iron in the mitochondria of erythroid precursor cells, resulting in the formation of sideroblastic rings. It occurs in both inherited and acquired forms. A prevalent subtype of congenital sideroblastic anemia (CSA) results from autosomal recessive mutations in the SLC25A38 gene. This investigation included a clinical and genetic evaluation of a family with a child diagnosed with pyridoxine-refractory SA. Whole Exome Sequencing (WES) was performed on the patient to detect the genetic variation. Afterwards, to examine segregation, Sanger sequencing of the related gene was conducted on the patient’s parents and the fetus of this family. On the other hand, the proband’s aunt and her husband, whose daughter died from symptoms similar to SA, were also evaluated for this variation. The next step involved molecular docking studies for the SLC25A38 protein pre- and post-variation. The WES analysis demonstrated the c.482_485del (p. Ile161ThrfsTer4) variant in the SLC25A38 gene, present in the probands as homozygotes and in the parents as heterozygotes. The chemical binds and stability of the protein in the mutant form was observed to be diminished in comparison to the wild form. This study enabled the reclassification of the SLC25A38: c.482_485del from likely pathogenic to pathogenic, which will significantly assist specialists in making decisions about this variant.

Indexed as

Anemia, SideroblasticFrameshift MutationMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial ProteinsChild, PreschoolExome SequencingFemaleHumansIranMaleMolecular Docking SimulationPedigreeMitochondrial Membrane Transport ProteinsMitochondrial ProteinsSlc25a38 protein, humanIranSideroblastic anemiaSLC25A38Variant reclassificationWES

Identifiers

PMID41714435
PMCPMC12920759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.